Participants 67 101 7
women treated with soy isoflavones
Participants 182 246 4
women who do and who do not produce equol, a daidzein metabolite
Participants 350 377 8
96 healthy menopausal women
Participants 441 527 3
women in the study group were assigned to the equol-producing (EP) or the non-EP group
Participants 949 1025 3
improves menopausal symptoms only in women with the ability to produce equol
